EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ENDRA Life Sciences's enterprise value is $1.17 Mil.
ENDRA Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, ENDRA Life Sciences's EV-to-Revenue for today is .
The historical rank and industry rank for ENDRA Life Sciences's EV-to-Revenue or its related term are showing as below:
During the past 10 years, the highest EV-to-Revenue of ENDRA Life Sciences was 2259.90. The lowest was -1065.66. And the median was 0.66.
NDRA's EV-to-Revenue is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 3.04 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for ENDRA Life Sciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ENDRA Life Sciences's EV-to-Revenue
For the Diagnostics & Research subindustry, ENDRA Life Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ENDRA Life Sciences's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, ENDRA Life Sciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where ENDRA Life Sciences's EV-to-Revenue falls into.
ENDRA Life Sciences's current Enterprise Value is $1.17 Mil.
ENDRA Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ENDRA Life Sciences (NAS:NDRA) EV-to-Revenue Explanation
ENDRA Life Sciences's share price for today is $0.3267.
ENDRA Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ENDRA Life Sciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of ENDRA Life Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
ENDRA Life Sciences (ENDRA Life Sciences) Business Description
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NDRA has been successfully added to your 